Sign In
Buy UHS
$142.87
-2.30 (-1.58%)
At Close: Jun 08, 2026
Universal Health Services (UHS) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
07:30pm, Wednesday, 26'th Feb 2025
Although the revenue and EPS for Universal Health Services (UHS) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compa
Universal Health Services (UHS) Beats Q4 Earnings and Revenue Estimates
06:30pm, Wednesday, 26'th Feb 2025
Universal Health Services (UHS) came out with quarterly earnings of $4.92 per share, beating the Zacks Consensus Estimate of $4.19 per share. This compares to earnings of $3.13 per share a year ago.
Universal Health Services beats fourth-quarter profit estimates on higher hospital admissions
06:02pm, Wednesday, 26'th Feb 2025
Hospital operator Universal Health Services beat fourth-quarter profit estimates on Wednesday, driven by robust demand for medical care that required hospital stays.
UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES 2024 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS AND 2025 OPERATING RESULTS FORECAST
04:16pm, Wednesday, 26'th Feb 2025
Consolidated Results of Operations, As Reported and As Adjusted – Three-month periods ended December 31, 2024 and 2023: KING OF PRUSSIA, Pa. , Feb. 26, 2025 /PRNewswire/ -- Universal Health Servic
Universal Health to Report Q4 Earnings: What Do the Estimates Say?
01:20pm, Monday, 24'th Feb 2025
UHS' fourth-quarter earnings are likely to have benefited from growing admissions and patient days.
Gear Up for Universal Health Services (UHS) Q4 Earnings: Wall Street Estimates for Key Metrics
10:21am, Monday, 24'th Feb 2025
Beyond analysts' top -and-bottom-line estimates for Universal Health Services (UHS), evaluate projections for some of its key metrics to gain a better insight into how the business might have performe
UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT MARCH HEALTHCARE CONFERENCES
04:30pm, Friday, 21'st Feb 2025
KING OF PRUSSIA, Pa. , Feb. 21, 2025 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that Steve Filton, Executive Vice President, and Chief Financial Officer will present a
UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DIVIDEND
04:30pm, Wednesday, 12'th Feb 2025
KING OF PRUSSIA, Pa. , Feb. 12, 2025 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that its Board of Directors voted to pay a cash dividend of $0.20 per share on March 17
Universal Health Services: A Quality GARP Company With Significant Upside
05:19pm, Sunday, 09'th Feb 2025
Universal Health Services (UHS) remains a BUY due to stable long-term fundamentals, consistent revenue growth, and improving margins. UHS's strong financial performance, including a 45% increase in ad
Thriving in Healthcare: 5 Hospital Stocks to Keep on Your Radar
10:30am, Monday, 03'rd Feb 2025
The Zacks Medical-Hospital industry is likely to benefit from improving financial, operating and staffing stability. Companies like HCA, THC, UHS, ACHC and CYH are well-positioned to gain from these t
UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR EARNINGS RELEASE AND CONFERENCE CALL
04:30pm, Wednesday, 22'nd Jan 2025
KING OF PRUSSIA, Pa. , Jan. 22, 2025 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that it will report results for its fourth quarter and full year ended December 31, 202
Universal Health Stock Trading at Attractive Valuation: Time to Buy?
04:01pm, Tuesday, 07'th Jan 2025
With UHS stock trading at a discount, we examine its growth drivers and challenges to determine if it presents a strong investment opportunity for investors at this time.
Tenet Healthcare downgraded to Neutral from Buy at Goldman Sachs
05:18am, Monday, 16'th Dec 2024
Goldman Sachs analyst Jamie Perse downgraded Tenet Healthcare to Neutral from Buy with a price target of $140, down from $196. Amid rising policy uncertainty, with a wide range of potential outcomes,
LifeStance upgraded to Buy from Neutral at Goldman Sachs
05:17am, Monday, 16'th Dec 2024
Goldman Sachs upgraded LifeStance to Buy from Neutral with a $10 price target. Amid rising policy uncertainty, with a wide range of potential outcomes, Goldman is taking a more cautious view on health
Universal Health downgraded to Neutral from Buy at Goldman Sachs
05:16am, Monday, 16'th Dec 2024
Goldman Sachs downgraded Universal Health to Neutral from Buy with a price target of $198, down from $228. Amid rising policy uncertainty, with a wide range of potential outcomes, Goldman is taking a
